• No results found

Aggressive Tumor

Thymic large cell neuroendocrine carcinoma – a rare and aggressive tumor: a case report

Thymic large cell neuroendocrine carcinoma – a rare and aggressive tumor: a case report

... grade tumor composed of large cells with neuroendocrine ...the tumor has organoid architecture and cells are arranged in nests and trabeculas with rosette-like ...grade tumor, the Ki-67 proliferation ...

6

A Rare Highly Aggressive Tumor of the Kidney: The Pure Epithelioid Angiomyolipoma

A Rare Highly Aggressive Tumor of the Kidney: The Pure Epithelioid Angiomyolipoma

... Case Presentation: A 51 year-old man presented with a persistant pain in the left lumbar region. Imaging revealed a left kidney tumor that was hemorrhagic and necrotic on gross examination. At histology, ...

5

Optimal Immunotherapy Control of Aggressive Tumors Growth

Optimal Immunotherapy Control of Aggressive Tumors Growth

... for aggressive tumor growth via a new and proper approach known as AVK method has been ...in tumor cells and also we have added Interlukin-2 (IL-2) into our treatment model to minimize the population ...

8

Endolymphatic sac tumors’: a surgical dilemma – to operate or not?

Endolymphatic sac tumors’: a surgical dilemma – to operate or not?

... locally aggressive tumor with a high propensity to cause bone erosion and invasion to adjacent structures (Wick, ...sac tumor includes other destructive lesions of the temporal bone such as ...

5

Aggressive angiomyxoma of the liver: a case report and literature review

Aggressive angiomyxoma of the liver: a case report and literature review

... The ideal treatment of AAM is complete surgical exci- sion with a wide margin, because AAM is a locally aggressive tumor. However, another study asserted that the recurrence rate in patients with narrow ...

6

Pleuropulmonary Blastoma: Case Report

Pleuropulmonary Blastoma: Case Report

... Pleuropulmonary blastoma (PPB) is a rare and aggressive tumor that is emerging as a distinct entity of childhood disease .It is characterized by mesenchymal elements (including undifferentiated blastoma and ...

5

www.ijcep.com /ISSN: 1936-2625/IJCEP1111016 Case Report Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report

www.ijcep.com /ISSN: 1936-2625/IJCEP1111016 Case Report Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report

... Abstract: In 2006, dedifferentiated endometrioid adenocarcinoma (undifferentiated carcinoma associated with low- grade endometrioid carcinoma) of the uterus was first proposed. Dedifferentiated endometrioid carcinoma is ...

6

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity

... It was subsequently aimed to determine the influence of CD44 expression on VM-characteristic network formation on a 3-dimensional matrix. Using siRNA knockdown, CD44 was suppressed by 50-75% at the RNA level, while ...

13

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas

Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas

... highly aggressive tumor cells and possibly aid the planning of patient treatment as tumor progression ...While tumor “ omics ” profiling promises a future of personal- ized treatment, the ...

6

RUNX2 and WWOX genes as molecular biomarkers and candidates for targeted therapy in Egyptian patients with primary conventional osteosarcoma

RUNX2 and WWOX genes as molecular biomarkers and candidates for targeted therapy in Egyptian patients with primary conventional osteosarcoma

... the aggressive tumor types provid- ing an evidence for the prognostic value of RUNX2 in conventional OS and confirming previous reports in literature in this context [24, ...the tumor leading to ...

9

The expression of the ubiquitin ligase subunit Cks1 in human breast cancer

The expression of the ubiquitin ligase subunit Cks1 in human breast cancer

... as tumor size and grade, lymph node sta- tus, and the expression of receptors to estrogen (ERs) and to progesterone (PRs) and of Her2/neu ...to aggressive tumor ...

8

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget

Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget

... cancer, tumor cells having undergone EMT are histologically represented by the presence of tumor buds defined as single cells or small clusters of de-differentiated tumor cells at the invasive ...

11

Original Article Expression of Eag1 K+ channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells

Original Article Expression of Eag1 K+ channel and ErbBs in human pituitary adenomas: cytoskeleton arrangement patterns in cultured cells

... in tumor pituitary cells have been associated with cell transformation to an inva- sive phenotype [14-17], as is seen in other tumor cells ...many tumor types, making them potential tools for the ...

11

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

... Results: This study characterized the grade, molecular subtypes, and proliferation index of these tumors and determined if TIL density was enriched across any of these factors. We analyzed 49 malignant patient tissue ...

11

Unusual multifocal intraosseous papillary intralymphatic angioendothelioma (Dabska tumor) of facial bones: a case report and review of literature

Unusual multifocal intraosseous papillary intralymphatic angioendothelioma (Dabska tumor) of facial bones: a case report and review of literature

... Papillary intralymphatic angioendothelioma (PILA), ori- ginally termed as endovascular papillary angioendo- thelioma (EPA), or Dabska tumor, was first presented in 1969 by Maria Dabska where she presented cases ...

6

AggressiveAngiomyxoma of theVulva: LibyanFemaleCaseReport

Aggressive Angiomyxoma of the Vulva: Libyan Female Case Report Nuria B. Enesser 1, Jamela M. Boder 2,3* and Fathi B. Abdalla 3

... of tumor is generally low to moderate cells with scarce mitotic ...for aggressive angiomyxoma have been disappointing, probably due to the low mitotic activity (growth fraction of ...Most aggressive ...

8

Pleiotropic functions of the tumor  and metastasis suppressing matrix metalloproteinase 8 in mammary cancer in MMTV PyMT transgenic mice

Pleiotropic functions of the tumor and metastasis suppressing matrix metalloproteinase 8 in mammary cancer in MMTV PyMT transgenic mice

... breast tumor cell lines, originating from the same breast tumor but with opposite metastatic capabilities, revealed increased expres- sion of MMP-8 in the non-metastatic cell line and corre- sponding ...

13

Primary Epithlelioid Angiosarcoma Of The Maxilla Masquerading As A Poorly - Differentiated Carcinoma : Case Report

Primary Epithlelioid Angiosarcoma Of The Maxilla Masquerading As A Poorly - Differentiated Carcinoma : Case Report

... A differential diagnosis of sarcoma, aggressive odontogenic tumor and sqamous cell carcinoma were made at the conclusion of examination. Conventional and advanced imaging investigations revealed a diffuse ...

5

Expression of VEGF in breast lesions: an immunohistochemical study

Expression of VEGF in breast lesions: an immunohistochemical study

... Background: Breast cancer is the most frequent cancer in India. During the last few years, several investigators have focused on tumor angiogenesis as a critical step in cancer development and progression. Among ...

6

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran

Association of clinicopathologic characteristics and outcomes with <em>EZH2</em> expression in patients with breast cancer in East Azerbaijan, Iran

... IHC staining was performed in all the cases for ER, PR, HER2, Ki-67, P53, and EZH2 biomarkers. For histologic study, tumor samples were fixed in 10% buffered formalin and embedded as paraffin blocks. The sections ...

9

Show all 10000 documents...

Related subjects